Cell And Gene Therapy Global Market Opportunities And Strategies To 2035
By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2035
Cell And Gene Therapy Market Definition
Cell and gene therapy is a branch of advanced medicine that involves modifying or using living cells and genetic material to treat, prevent, or potentially cure diseases. Cell therapy works by introducing healthy or engineered cells into a patient to replace or repair damaged tissues, while gene therapy involves altering, replacing, or regulating genes within a patient’s cells to correct genetic disorders or modify disease pathways. The primary purpose of cell and gene therapy is to address the root cause of diseases rather than just managing symptoms. The cell and gene therapy market consist of sales by entities (organizations, sole traders and partnerships) of cell and gene therapy products that are used by healthcare providers, including hospitals and specialty care centers, for patients with complex, chronic, or life‑threatening conditions such as cancers, inherited genetic disorders, and degenerative diseases. The therapies are typically administered in controlled clinical settings by trained medical specialists during specific treatment episodes when conventional treatments have proven ineffective or when a curative approach is medically indicated.
Cell And Gene Therapy Market Size
The global cell and gene therapy market reached a value of nearly $15,929.5 million in 2025, having grown at a compound annual growth rate (CAGR) of 23.4% since 2020. The market is expected to grow from $15,929.5 million in 2025 to $44,198.2 million in 2030 at a rate of 22.6%. The market is then expected to grow at a CAGR of 21.1% from 2030 and reach $114,876.4 million in 2035. Growth in the historic period resulted from the shift toward personalized and precision medicine, expansion of clinical trials and robust therapeutic pipeline, rising healthcare spending and rise in investments in pharmaceutical and biotechnology companies. Factors that negatively affected growth in the historic period were high treatment and development costs and low healthcare access. Going forward, the rise in aging population, rising prevalence of cancer, rising burden of chronic and genetic diseases and rise in investments in cell and gene therapies will drive the growth. Factor that could hinder the growth of the cell and gene therapy market in the future include shortage of skilled workforce, stringent regulatory challenges and impact of trade war and tariffs.Cell And Gene Therapy Market Segmentation
The cell and gene therapy market is segmented by product, by application and by end user.By Product –
The cell and gene therapy market is segmented by product into:
- a) Cell Therapy
- b) Gene Therapy
By Application –
The cell and gene therapy market is segmented by application into:
- a) Oncology
- b) Neurological Disorders
- c) Other Applications
By End User –
The cell and gene therapy market is segmented by end user into:
- a) Hospitals
- b) Ambulatory Surgical Centers
- c) Cancer Care Centers
- d) Wound Care Centers
- e) Other End‑Users
By Geography - The cell and gene therapy market is segmented by geography into:
- • China
- • India
- • Japan
- • Australia
- • Indonesia
- • South Korea
- • USA
- • Canada
- • Brazil
- • France
- • Germany
- • UK
- • Italy
- • Spain
- • Russia
-
o Asia Pacific
o Africa